« Back
Home /
KCTD11 (potassium channel tetramerisation domain containing 11)

KCTD11 (potassium channel tetramerisation domain containing 11)

Item no.	18-003-43897
Manufacturer	GENWAY
Amount	0.1 mg
Category	Oncology Antibodies Western Blot Cardiovascular Research Ischemia & Reperfusion Injury Primary Antibodies By Organ Brain Cancer
Type	Antibody
Applications	WB
Specific against	other
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	GWB-D82207
Similar products	18-003-43897
Available
Genway ID:	GWB-D82207
Antigen Specificity:	Polyclonal antibody produced in rabbits immunized with a synthetic peptide corresponding to a region of Human KCTD11.
ELISA Titre:	1:62500
Note:	Suggested starting concentrations are provided. Optimal dilutions should be determined by end-user. Differences in calculated versus apparent molecular weight may be due to post-translational modifications or protein hydrophobicity. The KCTD11 gene encodes a protein that has been identified as a suppressor of Hedgehog signaling. Its inactivation might lead to a deregulation of the tumor-promoting Hedgehog pathway in medulloblastoma.
Function:	Play a role as a marker and a regulator of neuronal differentiation; Up-regulated by a variety of neurogenic signals such as retinoic acid epidermal growth factor/EGF and NGFB/nerve growth factor. Induces apoptosis growth arrest and the expression of cyclin-dependent kinase inhibitor CDKN1B. Plays a role as a tumor repressor and inhibits cell growth and tumorigenicity of medulloblastoma (MDB). Functions as antagonist of the Hedgehog pathway on cell proliferation and differentiation by affecting the nuclear transfer of transcrition factor GLI1 thus maintaining cerebellar granule cells in undifferentiated state. When knock-down Hedgehog antagonism is impaired and proliferation of granule cells is sustained. Activates the caspase cascade.
Tissue Specificity:	Higher expression in cerebellum than in whole brain and lower expression in medulloblastoma.
Domain:	The BTB domain is required for growth-suppressing properties.
Disease:	Haploinsufficiency of KCTD11 may be a cause of development of medulloblastoma (MDB). MDB is a malignant invasive embryonal tumor of the cerebellum with a preferential manifestation in children. An allelic deletion involving genes from chromosome region 17p11. 2-pter sometimes restricted to 17p13. 2-13. 3 occurs in up to 50% of MDB.
Similarity:	Contains 1 BTB (POZ) domain. Di (2004) Proc. Natl. Acad. Sci. U. S. A. 101 (29). 10833-10838.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.1 mg

available

Delivery expected until 9/11/2025

Express Delivery: Save 7 days

Compare

Add to wishlist

Get an offer